Market Segmentation:
- By Product Type
- In-vitro Diagnostics (IVD)
- Skin Tests
- Patch Tests
- Challenge Tests
- Others (Blood Tests, Oral Food Challenge Tests)
- By Allergen Type
- Inhalants (Pollen, Dust Mites, Mold, Pet Dander)
- Foods (Peanuts, Tree Nuts, Shellfish, Eggs, Milk)
- Insect Venom
- Drugs
- Latex
- Others (Metals, Preservatives, Fragrances)
- By End-User
- Hospitals
- Diagnostic Laboratories
- Clinics
- Home Care Settings
- Others (Research Institutes, Pharmaceutical Companies)
- By Test Type
- Skin Prick Tests
- Intradermal Tests
- Patch Tests
- Oral Food Challenge Tests
- In-vitro Specific IgE Tests
- Component-Resolved Diagnostics
- Others (Basophil Activation Tests, Lymphocyte Transformation Tests)
- By Technology
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Radioallergosorbent Test (RAST)
- Multiplex Assays
- Molecular Diagnostics
- Others (Chemiluminescence, Flow Cytometry)
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East, and Africa
Frequently Asked Questions
The Allergy Diagnostics Market had an estimated market size worth US$ 5.8 billion in 2023.
The key factors driving the growth of the Allergy Diagnostics Market include the increasing prevalence of allergic conditions, advancements in diagnostic technologies, rising awareness about the importance of early diagnosis, expanding healthcare access, and the growing demand for personalized allergy management solutions.
Some of the key factors hampering the growth of the Allergy Diagnostics Market include the high cost of advanced allergy tests, limited reimbursement coverage in certain regions, complexities in allergy testing and interpretation, and the lack of access to allergy testing in underdeveloped regions.
The leading component segment in the Allergy Diagnostics Market is the In-vitro Diagnostics (IVD) category, which is expected to account for over 45% of the global market share by 2024.
The major players operating in the Allergy Diagnostics Market include Thermo Fisher Scientific, Siemens Healthineers, Danaher Corporation (Beckman Coulter), bioMérieux SA, Hitachi Chemical Diagnostics, and Hycor Biomedical, among others.
The Allergy Diagnostics Market is expected to grow at a CAGR of 6.8% from 2024 to 2031, reaching a global market valuation of US$ 9.8 billion by 2031.
The key drivers of the Allergy Diagnostics Market include the increasing prevalence of allergic conditions, advancements in diagnostic technologies, rising awareness about the importance of early diagnosis, expanding healthcare access, and the growing demand for personalized allergy management solutions.